# To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI

> **NCT02145897** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Kasiak Research Pvt. Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **BIOLOGICAL:** Autologous Stromal Vascular Fraction (SVF)
- **BIOLOGICAL:** Autologous Adipose Derieved MSCs
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT02145897
- **Lead sponsor:** Kasiak Research Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2015-08
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145897, "To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02145897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*